Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(7%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_2
6
40%
Ph phase_4
4
27%
Ph phase_1
2
13%
Ph not_applicable
2
13%
Ph phase_3
1
7%

Phase Distribution

2

Early Stage

6

Mid Stage

5

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
2(13.3%)
Phase 2Efficacy & side effects
6(40.0%)
Phase 3Large-scale testing
1(6.7%)
Phase 4Post-market surveillance
4(26.7%)
N/ANon-phased studies
2(13.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)
Other(5)

Detailed Status

Completed7
unknown5
Not yet recruiting1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (13.3%)
Phase 26 (40.0%)
Phase 31 (6.7%)
Phase 44 (26.7%)
N/A2 (13.3%)

Trials by Status

completed747%
not_yet_recruiting17%
withdrawn17%
recruiting17%
unknown533%

Recent Activity

1 active trials
Showing 5 of 15
recruitingphase_3

Fibrinogen Early In Severe Trauma StudY II

NCT05449834
not_yet_recruitingnot_applicable

Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy

NCT06582420
unknownphase_2

Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery

NCT04807621
withdrawnphase_1

A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)

NCT02528708
unknownphase_2

Fibrinogen Early In Severe Trauma studY Junior

NCT03508141
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT05449834Phase 3

Fibrinogen Early In Severe Trauma StudY II

Recruiting
NCT06582420Not Applicable

Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy

Not Yet Recruiting
NCT04807621Phase 2

Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery

Unknown
NCT02528708Phase 1

A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)

Withdrawn
NCT03508141Phase 2

Fibrinogen Early In Severe Trauma studY Junior

Unknown
NCT03014700Phase 4

Fibrinogen Concentrate vs Cryoprecipitate

Completed
NCT03884725Phase 4

Fibrinogen Concentrate In Children Cardiac Surgery 2

Unknown
NCT03801135Not Applicable

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Unknown
NCT02864875Phase 4

Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial

Completed
NCT02745041Phase 2

Fibrinogen Early In Severe Trauma studY

Completed
NCT00994045Phase 4

Fibrinogen as an Alternative to FFP in Aortic Surgery.

Completed
NCT02203968Phase 1

Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)

Completed
NCT02542306Phase 2

Safety and Efficacy of Fibrinogen Concentrate in Aortic Arch Surgery Involving Moderate Hypothermic Circulatory Arrest

Unknown
NCT01359878Phase 2

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial

Completed
NCT01187225Phase 2

Fibrinogen Concentrate In Children After Cardiac Surgery

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15